Division of Neurology, Toronto Western Hospital, Krembil Neuroscience Centre, University of Toronto, Toronto, Ontario, Canada.
Epilepsia. 2010 Jul;51(7):1314-6. doi: 10.1111/j.1528-1167.2009.02408.x. Epub 2009 Nov 16.
Dravet syndrome is a genetically determined severe epilepsy associated with cognitive decline and ataxia. The many types of seizures seen in these patients are typically pharmacoresistant. Here we describe two adults with Dravet syndrome who were treated with thalamic deep brain stimulation (DBS) and followed for 10 years. One patient with partial onset seizures received DBS at age 19 and showed a marked improvement in seizure control after DBS insertion and stimulation. The other patient with generalized onset seizures received DBS at age 34 and did not show any immediate benefit. No side effects or changes in cognition were observed in either of the patients. This is the first report of (short- and) long-term results in Dravet patients treated with thalamic DBS. We speculate that the results of DBS for epilepsy in patients with Dravet syndrome may be related to age at initiation of DBS treatment and seizure type.
德拉维特综合征是一种由基因决定的严重癫痫,伴有认知能力下降和共济失调。这些患者出现的多种类型的癫痫发作通常对药物治疗具有耐药性。在这里,我们描述了两名接受丘脑深部脑刺激 (DBS) 治疗并随访 10 年的德拉维特综合征成年患者。一名部分发作性癫痫患者在 19 岁时接受了 DBS 治疗,在 DBS 植入和刺激后癫痫控制明显改善。另一名全身性发作性癫痫患者在 34 岁时接受了 DBS 治疗,但没有立即受益。在这两名患者中均未观察到任何副作用或认知能力变化。这是首例接受丘脑 DBS 治疗的德拉维特综合征患者的(短期和)长期结果报告。我们推测,DBS 治疗德拉维特综合征患者癫痫的结果可能与 DBS 治疗开始时的年龄和癫痫类型有关。